Soteropoulos Paula has filed 18 insider transactions across 3 companies since January 2023.
Most recent transaction: a option exercise of 599 shares of Dianthus Therapeutics, Inc. /DE/ ($DNTH) on March 31, 2026.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Soteropoulos Paula | Not found | M | Stock Option (Right to Buy) | 599 | $0.00 | 599.0000 | 42,876,015 | 50.00% | 0.00% |
| March 31, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Soteropoulos Paula | Not found | S | Common Stock | 599 | $80.11 | 0.0000 | 42,876,015 | 100.00% | 0.00% |
| March 31, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Soteropoulos Paula | Not found | M | Common Stock | 599 | $8.44 | 599.0000 | 42,876,015 | 9999.99% | 0.00% |
| March 24, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Soteropoulos Paula | Not found | M | Common Stock | 27594 | $8.44 | 27,594.0000 | 42,876,015 | 9999.99% | 0.06% |
| March 24, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Soteropoulos Paula | Not found | M | Stock Option (Right to Buy) | 27594 | $0.00 | 1,198.0000 | 42,876,015 | 95.84% | 0.06% |
| March 24, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Soteropoulos Paula | Not found | S | Common Stock | 27594 | $78.05 | 0.0000 | 42,876,015 | 100.00% | 0.06% |
| May 22, 2025 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Soteropoulos Paula | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 32,125,179 | 9999.99% | 0.04% |
| May 13, 2025 | Rallybio Corp | $RLYB | Soteropoulos Paula | Director | A | Option (Right to Buy) | 28500 | $0.00 | 28,500.0000 | 43,544,824 | 9999.99% | 0.07% |
| June 13, 2024 | uniQure N.V. | $QURE | Soteropoulos Paula | Director | S | Ordinary Shares | 2220 | $5.14 | 20,203.0000 | 48,384,510 | 9.90% | 0.00% |
| May 23, 2024 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Soteropoulos Paula | Not found | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Rallybio Corp | $RLYB | Soteropoulos Paula | Director | A | Option (Right to Buy) | 16500 | $0.00 | 16,500.0000 | 40,447,388 | 9999.99% | 0.04% |
| June 16, 2023 | uniQure N.V. | $QURE | Soteropoulos Paula | Director | S | Ordinary Shares | 2275 | $18.99 | 22,423.0000 | 47,436,335 | 9.21% | 0.00% |
| June 13, 2023 | uniQure N.V. | $QURE | Soteropoulos Paula | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 13, 2023 | uniQure N.V. | $QURE | Soteropoulos Paula | Director | A | Ordinary Shares | 8700 | $0.00 | 24,698.0000 | 47,436,335 | 54.38% | 0.02% |
| Feb. 27, 2023 | uniQure N.V. | $QURE | Soteropoulos Paula | Director | S | Ordinary Shares | 384 | $19.97 | 15,998.0000 | 46,735,045 | 2.34% | 0.00% |
| Jan. 18, 2023 | uniQure N.V. | $QURE | Soteropoulos Paula | Director | M | Stock Option (Right to Buy) | 6000 | $0.00 | 2,000.0000 | 46,735,045 | 75.00% | 0.01% |
| Jan. 18, 2023 | uniQure N.V. | $QURE | Soteropoulos Paula | Director | S | Ordinary Shares | 6000 | $22.59 | 16,382.0000 | 46,735,045 | 26.81% | 0.01% |
| Jan. 18, 2023 | uniQure N.V. | $QURE | Soteropoulos Paula | Director | M | Ordinary Shares | 6000 | $5.37 | 22,382.0000 | 46,735,045 | 36.63% | 0.01% |